You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Claims for Patent: 5,962,461


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,962,461
Title: Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
Abstract:A liquid pharmaceutical composition is contemplated that comprises a pharmaceutically effective amount of a bitter tasting drug dissolved or dispersed in an aqueous medium that is free of ethanol. That aqueous medium consists essentially of water, about 5 to about 30 weight percent polyvinylpyrrolidone, about 35 to about 55 weight percent of a C.sub.3 -C.sub.6 polyol, about 0.01 to about 0.5 weight percent ammonium glycyrrhizinate and one or more flavorants. The liquid composition is transparent and has a pleasant taste. The bitter tasting drugs claimed herein are vitamin and mineral preparations, trimethoprim, and guaifenesin.
Inventor(s): Anaebonam; Aloysius O. (Burlington, MA), Clemente; Emmett (Manchester, MA), Fawzy; Abdel A. (Groton, MA)
Assignee: Ascent Pediatrics, Inc. (Billerica, MA)
Application Number:09/011,156
Patent Claims: 1. A liquid pharmaceutical composition comprising a pharmaceutically effective amount of a bitter-tasting drug dissolved or dispersed in an aqueous medium that is free of ethanol, said aqueous medium consisting essentially of water, about 5 to about 30 weight percent polyvinylpyrrolidone, about 35 to about 55 weight percent of a C.sub.3 -C.sub.6 polyol, about 0.01 to about 0.5 weight percent ammonium glycyrrhizinate and one or more flavorants, said liquid composition being transparent and having a pleasant taste when administered orally, wherein said bitter-tasting drug is selected from the group consisting of a vitamin preparation and minerals.

2. The liquid pharmaceutical composition according to claim 1 wherein said polyvinylpyrrolidone is present at about 7 to about 15 weight percent.

3. The liquid pharmaceutical composition according to claim 1 wherein said C.sub.3 -C.sub.6 polyol is present as a mixture of C.sub.3 polyols and C.sub.6 polyols.

4. The liquid pharmaceutical composition according to claim 1 wherein said ammonium glycyrrhizinate is present at a weight ratio to said drug of about 1:50 to 2:1.

5. The liquid pharmaceutical composition according to claims 1 wherein said drug is present in an amount of about 0.5 to about 5 weight percent.

6. A liquid pharmaceutical composition comprising about 0.5 to about 5 weight percent of a bitter-tasting drug dissolved or dispersed in an aqueous medium that is free of ethanol, said aqueous medium consisting essentially of water, about 7 to about 15 weight percent polyvinylpyrrolidone, about 45 to about 55 weight percent of a C.sub.3 -C.sub.6 polyol, about 0.01 to about 0.5 weight percent ammonium glycyrrhizinate and one or more flavorants, said ammonium glycyrrhizinate being present at a weight ratio to said drug of about 1:50 to about 1:10 and said liquid composition being transparent and having a pleasant taste when administered orally, wherein said bitter-tasting drug is selected from the group consisting of a vitamin preparation or minerals.

7. The liquid pharmaceutical composition according to claim 6 wherein said C.sub.3 -C.sub.6 polyol is present as a mixture of C.sub.3 polyols and C.sub.6 polyols.

8. The liquid pharmaceutical composition according to claim 7 wherein the weight ratio of said C.sub.3 polyol to said C.sub.6 polyol is about 1:4 to about 3:5.

9. The liquid pharmaceutical composition according to claim 6 wherein polyol other than a C.sub.6 polyol constitutes less than about 5 weight percent of said composition.

10. The liquid pharmaceutical composition according to claim 6 wherein said drug is present in an amount of about one to about 3 weight percent.

11. The liquid pharmaceutical composition according to claim 6 wherein said C.sub.3 -C.sub.6 polyol is present at about 45 to about 55 weight percent.

12. The liquid pharmaceutical composition according to claim 6 wherein said ammonium glycyrrhizinate is present at a weight ratio to said drug of about 1:50 to about 1:10.

13. A liquid pharmaceutical composition comprising a pharmaceutically effective amount of trimethoprim dissolved or dispersed in an aqueous medium that is free of ethanol, said aqueous medium consisting essentially of water, about 7 to about 15 weight percent polyvinylpyrrolidone, about 45 to about 55 weight percent of a C.sub.3 -C.sub.6 polyol, about 0.01 to about 0.5 weight percent ammonium glycyrrhizinate and one or more flavorants, said liquid composition being transparent and having a pleasant taste when administered orally.

14. The liquid pharmaceutical composition according to claim 13 wherein said C.sub.3 -C.sub.6 polyol is present as a mixture of C.sub.3 polyols and C.sub.6 polyols.

15. The liquid pharmaceutical composition according to claim 1 wherein said ammonium glycyrrhizinate is present at a weight ratio to said trimethoprim of about 1:50 to 1:10.

16. The liquid pharmaceutical composition according to claim 13 wherein said trimethoprim is present in an amount of about 0.5 to about 5 weight percent.

17. A liquid pharmaceutical composition comprising about 0.5 to about 5 weight percent of trimethoprim dissolved or dispersed in an aqueous medium that is free of ethanol, said aqueous medium consisting essentially of water, about 7 to about 15 weight percent polyvinylpyrrolidone, about 45 to about 55 weight percent of a C.sub.3 -C.sub.6 polyol, about 0.01 to about 0.5 weight percent ammonium glycyrrhizinate and one or more flavorants, said ammonium glycyrrhizinate being present at a weight ratio to said trimethoprim of about 1:50 to about 1:10 and said liquid composition being transparent and having a pleasant taste when administered orally.

18. The liquid pharmaceutical composition according to claim 17 wherein said C.sub.3 -C.sub.6 polyol is present as a mixture of C.sub.3 polyols and C.sub.6 polyols.

19. The liquid pharmaceutical composition according to claim 17 wherein the weight ratio of said C.sub.3 polyol to said C.sub.6 polyol is about 1:4 to about 3:5.

20. The liquid pharmaceutical composition according to claim 17 wherein a polyol other than a C.sub.6 polyol constitutes less than about 5 weight percent of said composition.

21. The liquid pharmaceutical composition according to claim 17 wherein said trimethoprim is present in an amount of about one to about 3 weight percent.

22. A liquid pharmaceutical composition comprising a pharmaceutically effective amount of guaifenesin dissolved or dispersed in an aqueous medium that is free of ethanol, said aqueous medium consisting essentially of water, about 7 to about 15 weight percent polyvinylpyrrolidone, about 45 to about 55 weight percent of a C.sub.3 -C.sub.6 polyol, about 0.01 to about 0.5 weight percent ammonium glycyrrhizinate and one or more flavorants, said liquid composition being transparent and having a pleasant taste when administered orally.

23. The liquid pharmaceutical composition according to claim 22 wherein said C.sub.3 -C.sub.6 polyol is present as a mixture of C.sub.3 polyols and C.sub.6 polyols.

24. The liquid pharmaceutical composition according to claim 22 wherein said ammonium glycyrrhizinate is present at a weight ratio to said guaifenesin of about 1:50 to 1:10.

25. The liquid pharmaceutical composition according to claim 22 wherein said guaifenesin is present in an amount of about 0.5 to about 5 weight percent.

26. A liquid pharmaceutical composition comprising about 0.5 to about 5 weight percent of guaifenesin dissolved or dispersed in an aqueous medium that is free of ethanol, said aqueous medium consisting essentially of water, about 7 to about 15 weight percent polyvinylpyrrolidone, about 45 to about 55 weight percent of a C.sub.3 -C.sub.6 polyol, about 0.01 to about 0.5 weight percent ammonium glycyrrhizinate and one or more flavorants, said ammonium glycyrrhizinate being present at a weight ratio to said guaifenesin of about 1:50 to about 1:10 and said liquid composition being transparent and having a pleasant taste when administered orally.

27. The liquid pharmaceutical composition according to claim 26 wherein said C.sub.3 -C.sub.6 polyol is present as a mixture of C.sub.3 polyols and C.sub.6 polyols.

28. The liquid pharmaceutical composition according to claim 26 wherein the weight ratio of said C.sub.3 polyol to said C.sub.6 polyol is about 1:4 to about 3:5.

29. The liquid pharmaceutical composition according to claim 6 wherein polyol other than a C.sub.6 polyol constitutes less than about 5 weight percent of said composition.

30. The liquid pharmaceutical composition according to claim 26 wherein said guaifenesin is present in an amount of about one to about 3 weight percent.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.